Eur J Cardiovasc Nurs. 2026 Jan 9:zvag008. doi: 10.1093/eurjcn/zvag008. Online ahead of print.
ABSTRACT
This paper discusses whether there is a need to upskill nurses and allied professionals in light of recent developments in ribonucleic acid-based therapeutics (RNA-Tx) for cardiovascular disease (CVD). The paper highlights potential challenges related to knowledge and understanding surrounding RNA-Tx, and provides an overview of the RNA-Tx landscape in CVD to illustrate the expanding and future role these therapies will play in patient management. Finally, it discusses how nurses and allied professionals may enhance their knowledge of RNA-Tx, how they can keep up to date with rapid advances, and how they might support patients to augment their own genomic literacy.
PMID:41512116 | DOI:10.1093/eurjcn/zvag008